Search results
When Chris Westphal flunked his interview with the CIA, it strengthened his conviction that he was better suited to writing comedy than to espionage. Since then, he has gone on to write for the hit comedy series Murphy Brown and Baby Talk. Westphal is the author of "The Chronicles of Huttle," a four-book series of comedic novels featuring the hapless Tom Huttle. In the most recent book in the s…
Dr. Westphal is co-founder and General Partner of Longwood Fund and has spent over 20 years as a biotech CEO, entrepreneur, and investor. Dr. Westphal has been the co-founder, CEO, and lead investor of seven biotechnology companies that have completed initial public offerings (IPOs) and created sustained market value of over $45 billion and have developed and received FDA approval for over 10 ...
People also ask
Who is Dr Westphal?
Who is David Westphal?
How much does Christoph Westphal pay a Boston All-Star?
What happened to Lilly & Westphal?
VC and Serial Entrepreneur. In 2001, he worked with Robert Langer to found Mimeon based on work by Langer on glycoengineering; the company changed its name to Momenta Pharmaceuticals the next year and went public in 2004. [4] [5] [6] Westphal was the founding CEO. [6] Momenta brought to market the first generic, low-molecular-weight heparin. [5]
- Biomedicine
- American
Christopher R. Westphal About the author Over +35 years experience in the design and implementation of analytical systems using entity-based representations, graph analytics, and disambiguation.
“Christopher Westphal is a truly engaging, dynamic and fascinating speaker and presenter. He is passionate about his field of work. He is tremendously knowledgeable and demonstrates brilliance ...
- 500+
- 7.2K
- Self-employed
- Northern, Virginia, United States
May 3, 2018 · In 2010, Westphal formed the VC firm Longwood Fund with Rich Aldrich and Michelle Dipp. Longwood went on to back Verastem, which Westphal took public in 2012, and Flex Pharma, which he launched in ...
Jun 7, 2010 · Jan 5. Thank you for the terrific insights shared from top biopharma CEOs, heads of R&D, and leading academics. We look forward to more great conversations tomorrow! @LongwoodFund. #JPM23 #longwoodhealthcareleaders. 3. 4. Christoph Westphal. @drcwestphal.
